Responsive Image

 

 

Responsive Image

Enfermedades digestivas


Líneas de investigación:

Enfermedad inflamatoria intestinal (colitis ulcerosa y enfermedad de Crohn) y enfermedades relacionadas
Desarrollo de nuevas técnicas endoscópicas diagnósticas y terapéuticas para el diagnóstico de lesiones neoplásicas y preneoplásicas del tracto digestivo

Actividades del grupo:

Papel de la aféresis leucocitaria.

Características e historia natural de la enfermedad inflamatoria intestinal preclínica.

Enfermedad perianal. Eficacia de los tratamientos biológicos y papel de la resonancia magnética en su evaluación.

Eficacia de los fármacos biológicos en el tratamiento de las complicaciones de la enfermedad inflamatoria intestinal.

    Coordinador/a del grupo

  •   Jose Luis Cabriada Nuño
      Coordinador del grupo
      CV resumen


Integrantes del grupo

  Marta Aduna de Paz
 
 
  Juan Antonio Arévalo Serna
 
 
  Inmaculada Barredo Santamaría
 
 
  Ainara Elorza Echániz
 
 
  Alberto Fernández Atutxa
 
 
  Alain Huerta Madrigal
 
 
  Irene Moraleja Yudego
 
 
  Iago Rodríguez Lago
 
 
  Ainhoa Rodríguez Pescador
 
 
  Cristina San Juan López
 
 

Publicaciones del grupo:

Caldas M,Perez A,Castro M,Bujanda L,Lucendo AJ,Rodrigo L,Huguet JM,Perez J,Molina J,Barrio J,Fernandez L,Lanas A,Perona M,Dominguez M,Ortuño J,Gomez BJ,Almela P,Botargues JM,Núñez Ó,Modolell I,Gomez J,Ruiz R,De la Coba C,Huerta A,Iyo E,Pozzati L,Anton R,Barenys M,Angueira T,Fernández M,Campillo A,Alcedo J,Pajares R,Mego M,Bermejo F,Dominguez JL,Tito L,Fernandez N,Pabon M,Cosme A,Mata P,Alcaide N,Ariño I,Di T,Garre A,Puig I,Nyssen OP,Megraud F,O'Morain C,Gisbert JP,EuReg HP. European Registry on  Helicobacter pylori  Management: Effectiveness of First and Second-Line Treatment in Spain. Antibiotics-Basel. 2020. 10. (1):13. IF:4,639. (2).
Carretero C,Prieto C,Angos R,Betes M,Herraiz M,de la Riva S,Zozaya F,Fernandez M,Rodriguez I,Munoz M. Pan-enteric capsule for bleeding high-risk patients. Can we limit endoscopies?. Rev. Esp. Enferm. Dig. 2020. IF:2,086. (4).
Mesonero F,Julia B,Saldana R,Savini C,Canas M,Cea L,Feo L,Fernandez S,Rodriguez I,ACCU GAG. Self-medication with oral corticosteroids reported by patients with ulcerative colitis: characteristics, reasons and patients' behaviors. Eur. J. Gastroenterol. Hepatol. 2020. 33. (4):p. 501-507. IF:2,566. (4).
Rodriguez I,Marigorta UM,Acosta MB. Preclinical inflammatory bowel disease: back to the future. Gastroenterology. 2020. 160. (1):p. 475-476. IF:22,682. (1).
Canete F,Manosa M,Perez I,Barreiro M,Gonzalez RC,Nos P,Iglesias E,Gutierrez A,Bujanda L,Gordillo J,Rios R,Casanova MJ,Villoria A,Rodriguez I,Lopez P,Garcia A,Ramirez P,Navarro M,Taxonera C,Barrio J,Ramos L,Navarro P,Benitez O,Calafat M,Domenech E. Antitumor Necrosis Factor Agents to Treat Endoscopic Postoperative Recurrence of Crohn's Disease: A Nationwide Study With Propensity-Matched Score Analysis. Clin Transl Gastroenterol. 2020. 11. (8):p. 218-218. IF:4,488. (2).
Martin N,Rodriguez I,Barredo I,Cabriada JL. Apoptotic colitis owing to dolutegravir. Gastroenterol. Hepatol. 2020. 43. (10):p. 638-639. IF:2,102. (4).
Rodriguez I,Ramirez C,Merino O,Azagra I,Maiz A,Zapata E,Higuera R,Montalvo I,Fernandez M,Arreba P,Carrascosa J,Iriarte A,Munoz M,Cabriada JL,Barreiro M. Early microscopic findings in preclinical inflammatory bowel disease. Dig. Liver Dis. 2020. 52. (12):p. 1467-1472. IF:4,088. (2).
Barreiro M,Marin I,Rodriguez I,Guarner F,Espin E,Ferrer I,Gutierrez A,Beltran B,Chaparro M,Gisbert JP,Nos P,en representacion G. Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 2: Treatment. Gastroenterol. Hepatol. 2020. 43. (10):p. 649-658. IF:2,102. (4).
Rodríguez I,Gisbert JP. The role of immunomodulators and biologics in the medical management of stricturing Crohn's disease. J. Crohn's Colitis. 2020. 14. (4):p. 557-566. IF:9,071. (1).
Marin I,Zabana Y,Rodriguez I,Marin L,Acosta MB,Esteve M,en representacion Y. [COVID-19 and inflammatory bowel disease: questions arising from patient care and follow-up during the initial phase of the pandemic (February-April 2020)]. Gastroenterol. Hepatol. 2020. 43. (7):p. 408-413. IF:2,102. (4).
Chaparro M,Guerra I,Iborra M,Cabriada JL,Bujanda L,Taxonera C,Garcia V,Marin I,Barreiro M,Vera I,Martin MD,Hernandez B,Mesonero F,Sempere L,Gomollon F,Hinojosa J,Bermejo F,Beltran B,Rodriguez A,Banales JM,Olivares D,Aguilar P,Menchen L,Ferreiro R,Blazquez I,Benitez B,Guijarro LG,Marin A,Bernardo D,Gisbert JP,PREDICROHN Study Group from G. Usefulness of monitoring antitumor necrosis factor serum levels during the induction phase in patients with Crohn's disease. Eur. J. Gastroenterol. Hepatol. 2020. 32. (5):p. 588-596. IF:2,566. (4).
Rodriguez I,Castro J,Fernandez A,Mesonero F,Lopez A,Lopez A,Marquez L,Clos A,Canete F,Vicuna M,Nantes O,Merino O,Matallana V,Gordillo J,Elorza A,Vicente R,Casanova MJ,Ferreiro R,Perez P,Benitez JM,Taxonera C,Garcia MJ,Martin E,Aguirre U,Gisbert JP,Young GRP. Tacrolimus induces short-term but not long-term clinical response in inflammatory bowel disease. Aliment. Pharmacol. Ther. 2020. 51. (9):p. 870-879. IF:8,171. (1).
Ramos L,Hernandez A,Rodriguez I,Carrillo M,Cejas L,Elorza A,Alonso I,Vela M,Hidalgo A,Hernandez Alvarez N,Rodriguez GE,Rodriguez Y,Tardillo C,Diaz L,Eiroa D,Aduna M,Garrido MS,Larena JA,Cabriada JL,Quintero E. Usefulness of magnetic resonance enterography in the clinical decision-making process for patients with inflammatory bowel disease. Gastroenterol. Hepatol. 2020. 43. (8):p. 439-445. IF:2,102. (4).
Rodriguez I,Ramirez de la Piscina P,Elorza A,Merino O,Ortiz de Zarate J,Cabriada JL. Characteristics and prognosis of patients with inflammatory bowel disease during the SARS-CoV-2 pandemic in the Basque Country (Spain). Gastroenterology. 2020. 159. (2):p. 781-783. IF:22,682. (1).
Albéniz E,Gimeno AZ,Fraile M,Ibáñez B,Guarner C,Alonso P,Álvarez MA,Gargallo CJ,Pellisé M,Zabala FR,Herreros de Tejada A,Nogales Ó,Martínez D,Múgica F,Peña J,Espinós J,Huerta A,Álvarez A,Gonzalez JM,Navajas F,Martínez JG,Redondo E,Mas JM,Sábado F,Rivero L,Saperas E,Soto S,Rodríguez J,López L,Rodríguez M,Iriarte MR,González AE,Pardeiro R,Cortázar EV,Concepción M,Álvarez PH,Hernández JC,Cobian J,Santiago J,Jiménez A,López B,García O,Martínez F,Pérez F,Carbó J,Enguita M. Clinical validation of risk-scoring systems to predict risk of delayed bleeding after endoscopic mucosal resection of large colorectal lesions. Gastrointest. Endosc. 2020. 91. (4):p. 868-8783. IF:9,427. (1).
Skuja V,Nakov R,van Y,Rodriguez I,Acedo P,Mikolasevic I,Nitsche U,Heinrich H,Dignass A,Young GRP. How to start a Young GI Section in your country: A cookbook. United European Gastroenterol. J. 2020. 8. (3):p. 355-358. IF:4,623. (2).
Macaluso FS,Rodriguez I. JAK inhibition as a therapeutic strategy for inflammatory bowel disease. Curr. Drug Metab. 2020. 21. (4):p. 247-255. IF:3,731. (2).
Rivero L,Arnau C,Herrero J,Remedios D,Alvarez V,Albéniz E,Calvo P,Gordillo J,Puig I,López J,Huerta A,López M,Salces I,Peñas B,Parejo S,Rodriguez de Santiago E,Herraiz M,Carretero C,Gimeno AZ,Saperas E,Alvarez C,Moreira R,Rodriguez de Miguel C,Ocaña T,Moreira L,Carballal S,Sánchez A,Jung G,Castells A,Llach J,Balaguer F,Pellisé M. White-light Endoscopy is Adequate for Lynch Syndrome Surveillance in a Randomized and Non-inferiority Study. Gastroenterology. 2020. 158. (4):p. 895-9041. IF:22,682. (1).
Fiallegas M,Moraleja I,Sampedro B,de Castro L,Jiménez I,Martín N,Cabriada JL. Giant sigmoid diverticulum. Gastroenterol. Hepatol. 2020. 43. (1):p. 30-31. IF:2,102. (4).
Elorza A,Rodríguez I,Martínez P,Hidalgo A,Aguirre U,Cabriada JL. Gastrointestinal infection with Aeromonas: incidence and relationship to inflammatory bowel disease. Gastroenterol. Hepatol. 2020. 43. (10):p. 614-619. IF:2,102. (4).
Rodriguez I,Hoyo JD,Perez A,Garrido A,Casanova MJ,Chaparro M,Fernandez A,Castro J,Garcia MJ,Sanchez S,Ferreiro R,Baston I,Piqueras M,Careda LEIBD,Mena R,Suarez C,Cordon JP,Lopez A,Marquez L,Arroyo M,Alfambra E,Sierra M,Cano N,Delgado P,Morales V,Aparicio JC,Guerra I,Aullo C,Merino O,Arranz L,Hidalgo MA,Llao J,Plaza R,Molina G,Torres P,Perez P,Romero MG,Herrera C,Armesto E,Mesonero F,Frago S,Benitez JM,Calvo M,Martin MCL,Elorza A,Larena A,Pena E,Rodriguez MC,Miguel JD,Botella B,Olmos JA,Lopez L,Aguirre U,Gisbert JP,Young G. Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn's disease. United European Gastroenterol. J. 2020. 8. (9):p. 1056-1066. IF:4,623. (2).
Rivero L,Gavric A,Herrero J,Remedios D,Alvarez V,Albeniz E,Gordillo J,Puig I,Lopez J,Huerta A,Lopez M,Salces I,Penas B,Parejo S,Rodriguez E,Herraiz M,Carretero C,Gimeno AZ,Saperas E,Alvarez C,Arnau C,Ortiz O,Sanchez A,Jung G,Balaguer F,Pellise M. The "diagnose and leave in" strategy for diminutive rectosigmoid polyps in Lynch syndrome: a post hoc analysis from a randomized controlled trial. Endoscopy. 2020. IF:10,093. (1).
Rodriguez I,Barreiro M. Look at Both Sides of the Coin in Determining Risk of Complicated Crohn's Disease. Clin. Gastroenterol. Hepatol. 2020. 19(7):p. 1503-1504. IF:11,382. (1).
Heinrich H,Rodr?guez I,Nakov R,Skuja V,Acedo P,Nitsche U,Mikolasevic I,van Y,Friends Y. Young GI Societies in Europe: 2019 update. United European Gastroenterol. J. 2020. 8(2):p. 227-232. IF:4,623. (2).
Rodriguez I,Zabana Y,Barreiro M. Diagnosis and natural history of preclinical and early inflammatory bowel disease. Ann. Gastroenterol. 2020. 33(5):p. 443-452.

Sanchez Sanchez, Cesar, Hernani, Maria Tolin, Alvarez Calatayud, Guillermo, Miranda Cid, Carmen, Manuel Navas, Victor, Marin-Jimenez, Ignacio, Menchen, Luis, Garcia Fernandez, Paloma, Merino Sanchez-Canete, Ana, Arevalo, A., Aznal, E., Azual, P., Barros, P., Bautista, A., Blanco, M., Blasco-Alonso, J., Bodas, A., Botija, G., Busquets, E., Campoy, C., Carabano, I, Carro, M. A., Chicano, F. J., Crujeira, V, Donado, P., Eizaguirre, F. J., Escartin, L., Caamano B, Fernandez, Cebrian S, Fernandez, Fernandez, Fernandez, Gonzalez P, Ferrer, Galera, R., Galicia, G., Peris M, Garcia, Romero R, Garcia, de Caldas R, Gonzalez, Grande, L., Iglesias, C., Irastorza, I., Jimenez, S., Juste, M., La Orden, E., Lopez, M. J., Lorenzo, H., Loverdos, I, Magallares, L., Manzano, M. J., de Carpi J, Martin, Marugan, J. M., Masiques, M. L., Medina, E., Menendez, C., Montraveta, M., Moreno, A., Codoceo R A, Munoz, Ochoa, C., Ortigosa, L., Pena, L., Perez-Moneo, B., Pociello, N., Rivero, M. C., Rodriguez, A., Martinez C, Rodriguez, Romero, J., Rosell, A., Valverde F, Sanchez, Segarra, O., Solar, A., Soria, M., Torrecilla, J., Torres, R., Gomez C, Tutau, Vazquez, R., Vecino, R., Alvarez A M, Vegas, Aguilar, P., Andreu, M., Arajol, C., Baston, I, Benitez, J. M., Botellla, B., Calvo, M., Camacho, L., Carrillo, M., Ceballos, D., Crespo, B., Duque, J. M., Fernandez, L., Ferreiro, R., Ferrer, I, Fraile, M., Gallach, M., Gallego, M. R., Delgado E, Gomez, Guerra, I, Casbas A, Gutierrez, Villalba L, Hernandez, Huguet, J. M., Iborra, M., Leo, E., Lucendo, A. J., Perez T, Martinez, Mesonero, F., Miguel, J. O., Penate, M., Galindo P, Perez, Gisbert J, Perez, Piqueras, M., Plaza, R., Ramirez, J. J., Ramos, L., Gloria E, Rodriguez Gonzalez, Gutierrez C, Rodriguez, Rodriguez-Lago, I, Rubio, S., Sainz, E., Torres A, Sanchez, Sapina, A., Saro, C., Sese, E., Trapero, A. M., Vargas, M., Vega, P., Spanish Soc Pediat Gastroenterolog, Spanish Working Grp Crohns Dis Ulc. Status of transition care in inflammatory bowel disease in Spain. Different medical perspectives. Rev Esp Enferm Dig. 2019; 111(11): 833 - 838. FI: 1,858(Q4). DOI: 10.17235/reed.2019.6310/2019.

Rodriguez-Lago, Iago, Ferreiro-Iglesias, Rocio, Nos, Pilar, Gisbert, Javier P., GETECCU. Management of acute severe ulcerative colitis in Spain: A nationwide clinical practice survey. Gastroenterol. Hepatol.. 2019; 42(2): 90 - 101. FI: 1,126(Q4). DOI: 10.1016/j.gastrohep.2018.09.002.

Acedo, Pilar, Heinrich, Henriette, van Herwaarden, Yasmijn, Nakov, Radislav, Nitsche, Ulrich, Rodriguez-Lago, Iago, Salaga, Maciej, Skuja, Vita. UEG Young Talent Group: What do we do?. United Eur. Gastroenterol. J.. 2019; 7(1): 166 - 168. FI: 3,453(Q2). DOI: 10.1177/2397847319826451.

Calafat, M, Manosa, M, Panes, J, Nos, P, Iglesias, E, Vera, I, Lopez-Sanroman, A, Guardiola, J, Taxonera, C, Minguez, M, Martin, MD, de Castro, L, Riestra, S, Rivero, M, Garcia-Planella, E, Calvet, X, Garcia-Lopez, S, Andreu, M, Gomollon, F, Barrio, J, Esteve, M, Rodriguez, A, Gisbert, JP, Gutierrez, A, Hinojosa, J, Arguelles, F, Busquets, D, Bujanda, L, Lazaro, J, Sicilia, B, Merino, O, Martinez, P, Bermejo, F, Lorente, R, Barreiro-de-Acosta, M, Rodriguez, C, Fe, M, Piqueras, M, Romero, P, Rodriguez, E, Roncero, O, Llao, J, Alcain, G, Riera, J, Sierra, M, Salazar, LIF, Jair, V, Navarro, M, Montoro, MA, Munoz, C, Lucendo, AJ, Van Domselaar, M, Moraleja, I, Huguet, M, Ramos, L, Ramirez, P, Almeda, P, Pajares, R, Khorrami, S, Madrigal, RE, Sese, E, Trapero, AM, Legido, J, Abad, A, Canete, F, Cabre, E, Domenech, E. Risk of immunomediated adverse events or secondary loss of response to infliximab in elderly patients with inflammatory bowel disease: a cohort study of the ENEIDA registry. J. Crohns Colitis. 2019; 13(1): 328 - 329. FI: 7,827(Q1). DOI: 10.1093/ecco-jcc/jjy222.561.

Rodriguez-Lago, I., Castro-Poceiro, J., Fernandez-Clotet, A., Mesonero, F., Lopez-Sanroman, A., Lopez-Garcia, A., Marquez, L., Clos-Parals, A., Canete, F., Vicuna, M., Nantes, O., Merino, O., Matallana Royo, V., Gordillo, J., Elorza, A., Sanz, P., Casanova, M. J., Ferreiro-Iglesias, R., Perez-Galindo, P., Benitez, J. M., Taxonera, C., Garcia Garcia, M. J., Martin Arranz, E., Calafat, M., Martin-Cardona, A., Munoz Nunez, F., Miquel-Cusachs, J. O., Sainz Arnau, E., Gisbert, J. P., Young IBD Grp GETECCU. Efficacy and safety of tacrolimus in Crohn's disease: a nationwide, multi-centric study from GETECCU. J. Crohns Colitis. 2019; 13(1): 207 - 208. FI: 7,827(Q1). DOI: 10.1093/ecco-jcc/jjy222.347.

Rodriguez-Lago, I., Castro-Poceiro, J., Fernandez-Clotet, A., Mesonero, F., Lopez-Sanroman, A., Lopez-Garcia, A., Marquez, L., Clos-Parals, A., Canete, F., Vicuna, M., Nantes, O., Merino, O., Matallana Royo, V., Gordillo, J., Elorza, A., Vicente, R., Casanova, M. J., Ferreiro-Iglesias, R., Perez-Galindo, P., Benitez, J. M., Taxonera, C., Garcia Garcia, M. J., Arranz, E. Martin, Calafat, M., Martin-Cardona, A., Munoz Nunez, F., Miquel-Cusachs, J. O., Sainz Arnau, E., Gisbert, J. P., Young IBD Grp GETECCU. Efficacy and safety of tacrolimus in ulcerative colitis: a nationwide, multi-centre study from GETECCU. J. Crohns Colitis. 2019; 13(1): 52 - 53. FI: 7,827(Q1). DOI: 10.1093/ecco-jcc/jjy222.078.

Chaparro, Maria, Barreiro-de Acosta, Manuel, Echarri, Ana, Almendros, Rosendo, Barrio, Jesus, Llao, Jordina, Gomollon, Fernando, Vera, Maribel, Luis Cabriada, Jose, Guardiola, Jordi, Guerra, Ivan, Beltran, Belen, Roncero, Oscar, Busquets, David, Taxonera, Carlos, Calvet, Xavier, Ferreiro-Iglesias, Rocio, Ollero Pena, Virginia, Bernardo, David, Donday, Maria G., Garre, Ana, Godino, Ana, Diaz, Ana, Gisbert, Javier P.. Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients. Dig Dis Sci. 2019; 64(3): 846 - 854. FI: 2,937(Q3). DOI: 10.1007/s10620-018-5362-3.

Balsa A., Lojo-Oliveira L., Alperi-López M., García-Manrique M., Ordóñez-Cañizares C., Pérez L., Ruiz-Esquide V., Corrales A., Narváez J., Rey-Rey J., Rodríguez-Lozano C., Ojeda S., Muñoz-Fernández S., Nolla J.M., García-Torrón J., Gamero F., García-Vicuña R., Hernández-Cruz B., Campos J., Rosas J., García-Llorente J.F., Gómez-Centeno A., Cáliz R., Sanmartí R., Bermúdez A., Abasolo-Alcázar L., Fernández-Nebro A., Rodríguez-Rodríguez L., Marras C., González-Gay M.Á., Hmamouchi I., Martín-Mola E.. Prevalence of Comorbidities in Rheumatoid Arthritis and Evaluation of Their Monitoring in Clinical Practice: The Spanish Cohort of the COMORA Study. Reumatol. Clin.. 2019; 15(2): 102 - 108. FI: (Q). DOI: 10.1016/j.reuma.2017.06.002.

Rodriguez-Lago, Iago, Sempere, Laura, Gutierrez, Ana, Nunez, Andrea, Leo Carnerero, Eduardo, Hinojosa, Esther, Mora, Maria, Canete, Fiorella, Manosa, Miriam, Herrera, Claudia, Beltran, Belen, Fores, Ana, Arjona, Dolores, Barreiro-de Acosta, Manuel, Khorrami, Sam, Aguirre, Urko, Ginard, Daniel, Luis Cabriada, Jose. Granulocyte-monocyte apheresis: an alternative combination therapy after loss of response to anti-TNF agents in ulcerative colitis. Scand. J. Gastroenterol.. 2019; 54(4): 459 - 464. FI: 2,152(Q4). DOI: 10.1080/00365521.2019.1600715.

Canete, Fiorella, Manosa, Miriam, Lobaton, Triana, Mesonero, Francisco, Rodriguez-Lago, Iago, Cabre, Eduard, Cabriada, Jose L., Lopez-Sanroman, Antonio, Domenech, Eugeni. Nivolumab-induced immune-mediated colitis: an ulcerative colitis look-alikereport of new cases and review of the literature. Int. J. Colorectal Dis.. 2019; 34(5): 861 - 865. FI: 2,641(Q2). DOI: 10.1007/s00384-019-03268-4.

Chaparro, Maria, Barreiro-de Acosta, Manuel, Manuel Benitez, Jose, Cabriada, Jose Luis, Jose Casanova, Maria, Ceballos, Daniel, Esteve, Maria, Fernandez, Hipolito, Ginard, Daniel, Gomollon, Fernando, Lorente, Rufo, Nos, Pilar, Riestra, Sabino, Rivero, Montserrat, Robledo, Pilar, Rodriguez, Cristina, Sicilia, Beatriz, Torrella, Emilio, Garre, Ana, Garcia-Esquinas, Esther, Rodriguez-Artalejo, Fernando, Gisbert, Javier P., EpidemIBD Study Grp GETECCU. EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain. Ther. Adv. Gastroenterol.. 2019; 12: UNSP 1756284819847034. FI: 3,961(Q2). DOI: 10.1177/1756284819847034.

Guerra I, Bujanda L, Castro J, Merino O, Tosca J, Camps B, Gutiérrez A, Gordillo Ábalos J, de Castro L, Iborra M, Carbajo AY, Taxonera C, Rodríguez-Lago I, Mesonero F, de Francisco R, Gómez-Gómez GJ, Chaparro M, Tardillo CA, Rivero M, Algaba A, Martín Arranz E, Cañete F, Vicente R, Sicilia B, Antolín B, Prieto V, Márquez L, Benítez JM, Camo P, Piqueras M, Gargallo CJ, Hinojosa E, Huguet JM, Pérez Calle JL, Van Domselaar M, Rodriguez C, Calvet X, Muñoz-Villafranca C, García-Sepulcre MF, Munoz-Garrido P, Fernández-Clotet A, Gómez Irwin L, Hernández S, Guardiola J, Sempere L, González Muñoza C, Hernández V, Beltrán B, Barrio J, Alba C, Moraleja I, López-Sanromán A, Riestra S, Martínez Montiel P, Garre A, Arranz L, García MJ, Martín Arranz MD, Corsino P, Arias L, Fernández-Salazar L, Fernández-Pordomingo A, Andreu M, Iglesias E, Ber Y, Mena R, Arroyo Villarino MT, Mora M, Ruiz L, López-Serrano P, Blazquez I, Villoria A, Fernández M, Bermejo F, Banales JM, Domènech E, Gisbert JP, Spanish GETECCU group (ENEIDA Project). Clinical characteristics, associated malignancies and management of primary sclerosing cholangitis in inflammatory bowel disease patients: A multicenter retrospective cohort study.. J. Crohns Colitis. 2019; 13(12): 1492 - 1500. FI: 7,827(Q1). DOI: 10.1093/ecco-jcc/jjz094.

Andújar X, Loras C, González B, Socarras M, Sanchiz V, Boscà M, Domenech E, Calafat M, Rodríguez E, Sicilia B, Calvet X, Barrio J, Guardiola J, Iglesias E, Casanova MJ, Ber Y, Monfort D, López-Sanromán A, Rodríguez-Lago I, Bujanda L, Márquez L, Martín-Arranz MD, Zabana Y, Fernández-Bañares F, Esteve M, ENEIDA registry of GETECCU. Efficacy and safety of endoscopic balloon dilation in inflammatory bowel disease: results of the large multicenter study of the ENEIDA registry.. Surg. Endosc.. 2019; 34(3): 1112 - 1122. FI: 3,209(Q1). DOI: 10.1007/s00464-019-06858-z.

de Miguel, Eugenio, Joven-Ibanez, Beatriz, Galindez, Eva, Urrego-Laurin, Claudia, Luz Garcia-Vivar, Maria, Fernandez-Carballido, Cristina, Garcia Llorente, Jose Francisco, Castro Villegas, Maria del Carmen, Tornero, Carolina, Juanola-Roura, Xavier, Esperanza Working Grp. THE VALUE OF SACROILIAC JOINT RADIOGRAPHS IN THE EARLY SPONDYLOARTHRITIS ESPERANZA COHORT. Ann. Rheum. Dis.. 2019; 78(2): 472 - 472. FI: 14,299(Q1). DOI: 10.1136/annrheumdis-2019-eular.7696.

Tornero, Carolina, Urrego-Laurin, Claudia, Luz Garcia-Vivar, Maria, Fernandez-Carballido, Cristina, Juanola-Roura, Xavier, Garcia Llorente, Jose Francisco, Castro Villegas, Maria del Carmen, Joven-Ibanez, Beatriz, Galindez, Eva, de Miguel, Eugenio, Esperanza Working Grp. RELIABILITY OF SACROILIAC JOINT RADIOGRAPHS IN THE EARLY SPONDYLOARTHRITIS ESPERANZA COHORT. Ann. Rheum. Dis.. 2019; 78(2): 1821 - 1821. FI: 14,299(Q1). DOI: 10.1136/annrheumdis-2019-eular.7768.

Irati, Urionaguena, Chinchilla Gallo, P. Sandra, Hernandez Gomez, Sandra, Garcia Llorente, Jose Francisco, Aizpurua Manso, Izaskun, Vegas Revenga, Nuria. DENSITOMETRY VALUES CHANGE WHEN STOPPING DENOSUMAB. Ann. Rheum. Dis.. 2019; 78(2): 1896 - 1896. FI: 14,299(Q1). DOI: 10.1136/annrheumdis-2019-eular.4338.

Domenech, Eugeni, Panes, Julian, Hinojosa, Joaquin, Annese, Vito, Magro, Fernando, Sturniolo, Giacomo Carlo, Bossa, Fabrizio, Fernandez, Francisco, Gonzalez-Conde, Benito, Garcia-Sanchez, Valle, Dignass, Axel, Herrera, Jose Manuel, Cabriada, Jose Luis, Guardiola, Jordi, Vecchi, Maurizio, Portela, Francisco, Ginard, Daniel. Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical Trial (vol 12, pg 687, 2018). J. Crohns Colitis. 2019; 13(6): 814 - 814. FI: 7,827(Q1). DOI: 10.1093/ecco-jcc/jjy211.

Rodríguez-Lago I, Barreiro-de Acosta M. Short Disease Duration Does Not Always Indicate Early Crohn's Disease.. Clin. Gastroenterol. Hepatol.. 2019; 17(8): 1646 - 1646. FI: 7,958(Q1). DOI: 10.1016/j.cgh.2019.01.017.

Carmona-Abellan, Mar, Rodriguez-Lago, Iago, Luis Cabriada, Jose, Carlos Gomez-Esteban, Juan. The relationship between inflammatory bowel disease and Parkinson's disease: true or fiction?. Scand. J. Gastroenterol.. 2019; 54(7): 886 - 889. FI: 2,152(Q4). DOI: 10.1080/00365521.2019.1641739.

Barreiro-De Acosta, Manuel, Domenech, Eugeni, Martin Arranz, Maria Dolores, Garcia Sanchez, Valle, Gutierrez Casbas, Ana, Chaparro, Maria, Alcain, Guillermo, Iborra, Marisa, Taxonera, Carlos, Rodriguez-Lago, Iago, Menchen, Luis, Khorrami, Sam, Romero, Cristina, Cea-Calvo, Luis, Julia, Berta. Endoscopic follow-up and therapeutic attitude after ileocolonic resection in a nationwide Spanish cohort of Crohn's disease patients: the Practicrohn study. Expert Rev. Gastroenterol. Hepatol.. 2019; 13(8): 807 - 813. FI: 2,991(Q3). DOI: 10.1080/17474124.2019.1626717.

Rodríguez-Lago I, Merino O, López de Goicoechea MJ, Aranzamendi M, Zubiaurre L, Muro N, Ortiz de Zárate J, Cilla G, Cabriada JL. Immunosuppression for inflammatory bowel disease does not influence Epstein-Barr viral load in the short-term.. Gastroenterol. Hepatol.. 2019; 42(9): 542 - 547. FI: 1,126(Q4). DOI: 10.1016/j.gastrohep.2019.03.016.

Casanova MJ, Chaparro M, Mínguez M, Ricart E, Taxonera C, García-López S, Guardiola J, López-San Román A, Iglesias E, Beltrán B, Sicilia B, Vera MI, Hinojosa J, Riestra S, Domènech E, Calvet X, Pérez-Calle JL, Martín-Arranz MD, Aldeguer X, Rivero M, Monfort D, Barrio J, Esteve M, Márquez L, Lorente R, García-Planella E, de Castro L, Bermejo F, Merino O, Rodríguez-Pérez A, Martínez-Montiel P, Van Domselaar M, Alcaín G, Domínguez-Cajal M, Muñoz C, Gomollón F, Fernández-Salazar L, García-Sepulcre MF, Rodríguez-Lago I, Gutiérrez A, Argüelles-Arias F, Rodriguez C, Rodríguez GE, Bujanda L, Llaó J, Varela P, Ramos L, Huguet JM, Almela P, Romero P, Navarro-Llavat M, Abad Á, Ramírez-de la Piscina P, Lucendo AJ, Sesé E, Madrigal RE, Charro M, García-Herola A, Pajares R, Khorrami S, Gisbert JP. Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry.. Inflammatory Bowel Dis.. 2019; 26(4): 606 - 616. FI: 4,005(Q2). DOI: 10.1093/ibd/izz192.

Chaparro M, Aterido A, Guerra I, Iborra M, Cabriada JL, Bujanda L, Taxonera C, García-Sánchez V, Marín-Jiménez I, Barreiro-de Acosta M, Vera I, Martín-Arranz MD, Hernández-Breijo B, Mesonero F, Sempere L, Gomollón F, Hinojosa J, Bermejo F, Beltrán B, Rodríguez-Pescador A, Banales JM, Olivares D, Aguilar-Melero P, Menchén L, Ferreiro-Iglesias R, Blazquez Gómez I, Benitez García B, Guijarro LG, Marin AC, Bernardo D, Marsal S, Julia A, Gisbert JP. Functional rare variants influence the clinical response to anti-TNF therapy in Crohn's disease. Ther. Adv. Gastroenterol.. 2019; 12: 1756284819867848. FI: 3,961(Q2). DOI: 10.1177/1756284819867848.

Barreiro-de Acosta, Manuel, Gutierrez, Ana, Rodriguez-Lago, Iago, Espin, Eloy, Ferrer Bradley, Isabel, Marin-Jimenez, Ignacio, Beltran, Belen, Chaparro, Maria, Gisbert, Javier P., Nos, Pilar, GETECCU. Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 1: Epidemiology, diagnosis and prognosis. Gastroenterol. Hepatol.. 2019; 42(9): 568 - 578. FI: 1,126(Q4). DOI: 10.1016/j.gastrohep.2019.08.001.

Rodriguez-Lago, Iago, Benitez, Jose M., Sempere, Laura, Saez-Gonzalez, Esteban, Barreiro-de Acosta, Manuel, de Zarate, Jone O., Cabriada, Jose L.. The combination of granulocyte-monocyte apheresis and vedolizumab: A new treatment option for ulcerative colitis?. J. Clin. Apheresis. 2019; 34(6): 680 - 685. FI: 3,088(Q2). DOI: 10.1002/jca.21746.

Tesis del grupo:

Autor/a: Iago Rodríguez Lago. Título: Enfermedad inflamatoria intestinal preclínica: características de la enfermedad, pronóstico y necesidades de tratamiento. Director: Dr. Miguel Muñoz Navas. Co-director: Manuel Barreiro de Acosta. Facultad de Medicina, Universidad de Navarra

© 2021 IIS Biocruces Bizkaia